A government benefits agency, faced with a legal defeat seven months ago, has at last backtracked. It has finally decided to abide by the judges’ ruling. It is now to change how it makes decisions about a key disability benefit.
People with serious illnesses need specialist medical care. That may be stating the obvious but my experience leads me to believe that it is not always true.
I received my diagnosis of having multiple sclerosis in 2002 in the UK and […]
“Oh, I am sorry.”
How often do you hear that? I am not referring to a normal everyday apology. No, I am talking about when someone hears, for the first time, that you have multiple sclerosis, or other serious illness or […]
Most people, myself included, tend to think of multiple sclerosis as a disease that affects adults. Although we know that it can affect children, they make up such a small percentage that it easy for us to forget them
The fact […]
I think it’s great that therapies approved as treatments for multiple sclerosis are to be compared for safety and effectiveness. The move is long overdue.
Corrona Multiple Sclerosis Registry, which is to carry out the work, has been set up as […]
Today, November 8 2017, I celebrate my 65th birthday, and have reached my retirement age. That is the age at which I can claim the national pension.
For many years the retirement age in the UK has been 65 for men […]
Complaints about assessments for a key government disability benefit have rocketed by 880% in 12 months, according to official figures. It is a benefit paid to people with diseases like multiple sclerosis and those with other disabilities.
Yes, claimants’ complaints about […]
A clinical study is to look at whether older people with MS can stop using disease modifying therapies (DMTs). The proposal has left me in two minds.
The idea seems to be that those who have not any relapses for a […]
Legalise medicinal cannabis is the call of the MS Society as it tries to persuade the UK government to act. And, as part of its campaign, the society is seeking to dispel some popular misconceptions. It has also produced its […]Read More
Multiple sclerosis organisations, and the media, are excited about new drug ibudilast. This follows a striking presentation at the ECTRIMS-ACTRIMS meeting in Paris.
So, what exactly is ibudilast and what can it do? Well, it’s an ant-inflammatory treatment but, for a […]